Valneva and Pfizer Report Further Positive Phase 2 Results, Including Booster Response, for Lyme Disease Vaccine Candidate: targets the outer surface protein A (OspA) of Borrelia burgdorferi... and covers the six OspA serotypes that are prevalent in North America & Europe
No comments:
Post a Comment